Stock & Company Details
Moderna Inc $MRNA
Price:
46,691,331
397M
$28B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-7.84
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
MRNA technical indicators
Latest Moderna Inc (MRNA) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
73.67 0.4%
MACD:
4.89 10.4%
SMA 50:
$51.78 0.6%
SMA 200:
$40.59 0.6%
EMA 20:
$58.32 2.2%
Bollinger Bands:
71.63 / 39.91
Stochastic:
92.99 9.4%
ADX 14:
29.33 7.0%
ATR 14:
4.42 0.6%
CCI 20:
143.06 0.2%
OBV:
13.85M 168.1%
ROC 12:
41.08% 20.3%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Finance Bot
Ask your questions
Start by typing a question below.
